Pilot phase IIA study for evaluation of the efficacy of folic acid in the treatment of laryngeal leucoplakia

Cancer

Volumn 107, Issue 2, 2006, Pages 328-336

  Almadori, Giovanni ^a,b   Bussu, Francesco ^a   Navarra, Pierluigi ^a   Galli, Jacopo ^a   Paludetti, Gaetano ^a   Giardina, Bruno ^a   Maurizi, Maurizio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Folate; Head and neck cancer; Laryngeal cancer; Molecular epidemiology

Indexed keywords

FOLIC ACID; FOLINA; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRINKING BEHAVIOR; DRUG EFFICACY; DYSPLASIA; FEMALE; FOLIC ACID BLOOD LEVEL; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; LARYNGOSCOPY; LARYNX TUMOR; LEUKOPLAKIA; MALE; MICROLARYNGOSCOPY; MOLECULAR EPIDEMIOLOGY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; AGED; FEMALE; FOLIC ACID; HUMANS; LARYNGEAL NEOPLASMS; LARYNGOSCOPY; LEUKOPLAKIA; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 33745819611     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22003     Document Type: Article

References (69)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin. 1995;45:352-368.
3. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-194.
4. Narayana A, Vaughan AT, Fisher SG, Reddy SP. Second primary tumors in laryngeal cancer: results of long-term follow-up. Int J Radiat Oncol Biol Phys. 1998;42:557-562.
5. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449-456.
6. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst. 1988;80:1237-1243.
7. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
8. Almadori G, Cadoni G, Cattani P, et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer. 1996;32A:783-788.
9. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37:477-492.
10. Almadori G, Paludetti G, Cerullo M, Ottaviani F, D'Alatri L. Marijuana smoking as a possible cause of tongue carcinoma in young patients. J Laryngol Otol. 1990;104:896-899.
11. Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999;8:1071-1078.
12. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 2002;112:1861-1865.
13. Lewin JS, Gillenwater AM, Garrett JD, et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer. 2003;97:1010-1014.
14. Califano J, van der RP, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-2492.
15. Homann N, Nees M, Conradt C, et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res. 2001;7:290-296.
16. Uhlman DL, Adams G, Knapp D, Aeppli DM, Niehans G. Immunohistochemical staining for markers of future neoplastic progression in the larynx. Cancer Res. 1996;56:2199-2205.
17. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6:733-743.
18. Lazarus P, Park JY. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol. 2000;36:421-431.
19. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst. 2001;93:1411-1418.
20. Scott JM, Weir DG. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J Cardiovasc Risk. 1998;5:223-227.
21. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130:129-132.
22. Bandera EV, Freudenheim JL, Marshall JR, et al. Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control. 1997;8:828-840.
23. Heimburger DC, Alexander CB, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA. 1988;259:1525-1530.
24. Saito M, Kato H, Tsuchida T, Konaka C. Chemoprevention effects on bronchial squamous metaplasia by folate and vitamin B12 in heavy smokers. Chest. 1994;106:496-499.
25. Baghurst PA, McMichael AJ, Slavotinek AH, et al. A case-control study of diet and cancer of the pancreas. Am J Epidemiol. 1991;134:167-179.
26. Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 2003;95:373-380.
27. Xiao SD, Meng XJ, Shi Y, et al. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. Gut. 2002;50:61-64.
28. van Niekerk W. Cervical cells in megaloblastic anaemia of the puerperium. Lancet. 1962;1:1277-1279.
29. Potischman N, Brinton LA, Laiming VA, et al. A case-control study of serum folate levels and invasive cervical cancer. Cancer Res. 1991;51:4785-4789.
30. Goodman MT, McDuffle K, Hernandez B, Wilkens LR, Selhub J. Case-control study of plasma folate, homocysteine, vitamin B(12), and cysteine as markers of cervical dysplasia. Cancer. 2003;89:376-382.
31. Buckley DI, McPherson RS, North CQ, Becker TM. Dietary micronutrients and cervical dysplasia in southwestern American Indian women. Nutr Cancer. 1992;17:179-185.
32. Brock KE, Berry G, Mock PA, et al. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst. 1988;80:580-585.
33. La Vecchia C, Braga C, Negri E, et al. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer. 1997;73:525-530.
34. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine-low- folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265-273.
35. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer. 1999;79:1917-1922.
36. Cravo ML, Mason JB, Dayal Y, et al. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 1992;52:5002-5006.
37. Kim YI, Salomon RN, Graeme-Cook F, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut. 1996;39:732-740.
38. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer. 2003;3:601-614.
39. Warnecke PM, Bestor TH. Cytosine methylation and human cancer. Curr Opin Oncol. 2000;12:68-73.
40. Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000;60:892-895.
41. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001;475:7-20.
42. Fenech M. Biomarkers of genetic damage for cancer epidemiology. Toxicology. 2002;181-182:411-416.
43. Melnyk S, Pogribna M, Miller BJ, et al. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett. 1999;146:35-44.
44. James SJ, Miller BJ, Basnakian AG, Pogribny IP, Pogribna M, Muskhelishvili L. Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. Carcinogenesis. 1997;18:287-293.
45. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J. 1998;12:1491-1497.
46. Wickramasinghe SN, Fida S. Bone marrow cells from vitamin B12- and folate-deficient patients misincorporate uracil into DNA. Blood. 1994;83:1656-1661.
47. Branda RF, Blickensderfer DB. Folate deficiency increases genetic damage caused by alkylating agents and gamma-irradiation in Chinese hamster ovary cells. Cancer Res. 1993;53:5401-5408.
48. Le Marchand L, Yoshizawa CN, Kolonel LN, Hankin JH, Goodman MT. Vegetable consumption and lung cancer risk: a population-based case-control study in Hawaii. J Natl Cancer Inst. 1989;81:1158-1164.
49. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 1995;87:1345-1347.
50. Almadori G, Bussu F, Galli J, et al. Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer. 2002;94:1006-1011.
51. Almadori G, Bussu F, Galli J, et al. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia. Cancer. 2005;103:284-292.
52. Fenech M. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res. 2001;480-481:51-54.
53. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 1976;36:2699-2702.
54. Pikaar NA, Wedel M, van der Beek EJ, et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism. 1987;36:538-543.
55. Johnson FL. Management of advanced premalignant laryngeal lesions. Curr Opin Otolaryngol Head Neck Surg. 2003;11:462-466.
56. Blackwell KE, Fu YS, Calcaterra TC. Laryngeal dysplasia. A clinicopathologic study. Cancer. 1995;75:457-463.
57. Sllamniku B, Bauer W, Painter C, Sessions D. The transformation of laryngeal keratosis into invasive carcinoma. Am J Otolaryngol. 1989;10:42-54.
58. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
59. Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope. 2001;111:1079-1087.
60. Khuri FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823-829.
61. Franchin G, Minatel E, Gobitti C, et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003;98:765-772.
62. Almadori G, Bussu F, Cadoni G, et al. MultiStep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur J Cancer. 2004;40:2383-2388.
63. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727-1730.
64. Blackwell KE, Calcaterra TC, Fu YS. Laryngeal dysplasia: epidemiology and treatment outcome. Ann Otol Rhinol Laryngol. 1995;104:596-602.
65. Zeitels SM, Hillman RE, Franco RA, Bunting GW. Voice and treatment outcome from phonosurgical management of early glottic cancer. Ann Otol Rhinol Laryngol Suppl. 2002;190:3-20.
66. Papadimitrakopoulou VA, dayman GL, Shin DM, et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1999;125:1083-1089.
67. Chiesa F, Tradati N, Grigolato R, et al. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Int J Cancer. 2005;115:625-629.
68. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst. 2000;92:977-986.
69. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000;72:998-1003.